infection resistant News
-
Multidrug-resistant bacteria remain a public health issue in Europe
On the occasion of the European Antibiotic Awareness Day, ECDC is releasing new European-wide surveillance data on antibiotic resistance from the European Antimicrobial Resistance Surveillance Network (EARS-Net). With annually up to 400,000 patients reported to suffer from infections resistant to multiple antibiotics, the data show that antibiotic resistance remains a public health problem across ...
-
Second Patent Issued for Healionics’ Textured STAR Biointerface
Healionics Corporation has received a further patent for its textured STAR Biointerface technology. The United States Patent and Trademark Office issued Patent No. 8,647,393, "Implantable Medical Devices Having Microporous Surface Layers and Method for Reducing Foreign Body Response to the Same.” This new patent extends the scope of 8,372,423 issued to Healionics in February 2013. The STAR ...
By Healionics
-
5 More Bad Bugs to Watch Out For
From vicious viruses to felonious fungi, these bad bugs are wanted for a wide array of sickening crimes. Cryptosporidium Despite breaking most of the rules, Cryptosporidium is a regular at the local recreation center. He can’t resist infecting innocent swimmers, but he can resist chlorine. Much like the diarrhea he leaves in his wake, Cryptosporidium strikes without warning and moves ...
-
Biopharmaceutical Leaders Announce New Effort to Tackle Superbugs, Spur Development of New Antibiotics
Today more than 20 leading biopharmaceutical companies announced the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as the threat of antimicrobial resistance, or AMR, continues to grow and claim more lives. In response to today’s launch of the fund, BIO issued the following statements celebrating the ...
-
Healionics raises $4.7M equity round to support commercialization of STARgraft vascular graf
Healionics Corporation, a private medical device company, announced today the completion of a $4.7M equity financing round led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest. Healionics is preparing to commercialize its innovative STARgraft vascular graft, designed to provide a safer and more reliable means to access ...
By Healionics
-
WHO calls for new innovations to tackle antimicrobial resistance crisis
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi Ondine’s nonantibiotic photodisinfection technology has been proven in Canadian hospitals to kill pathogens helping to generate 84% reduction of postoperative infection rates and significant cost savings. The World ...
-
ID Genomics’ CLoNeT E. coli Assay in Development to Combat Antibiotic Resistant Urinary Tract Infections
ID Genomics, SPC today announced the completion of its first Pre-Submission meeting with the Food and Drug Administration for the CLoNeT E. coli Assay for Urinary Tract Infections (UTIs). “We continue to make great strides in our development plans for the CLoNeT E. coli Assay,” said Linda Zuckerman, Ph.D., President and CEO. “This unique product will be able to detect the ...
-
Specific Diagnostics Commences US Clinical Trials for FDA 510(k) Clearance of its Reveal Rapid AST System
Specific Diagnostics announces today the commencement of its US clinical studies for the Reveal Rapid AST System for blood infection. Trials will entail 3 months of data collection followed by submission for FDA consideration of 510(k) clearance of the Reveal test. In Europe, where the Reveal is launched under CE-IVD registration, 11 studies across France and England comprising over 1,400 ...
-
Identifying Superbugs in New York Hospitals and Healthcare Environments
The Centers for Disease Control and Prevention (CDC) reports that on any given day, about 1 in 25 hospital patients has at least one healthcare-associated infection (HAI). Healthcare-associated infections are those infections that patients acquire during the course of receiving treatment for other conditions. A number of these infections are due to an expanding list of drug-resistant ...
-
CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections
CARB-X is awarding Vaxdyn, based in Seville, Spain, up to US$892,000, plus an additional $6.36 million if certain project milestones are met, to develop a new vaccine to prevent life-threatening drug-resistant infections, including pneumonia. Vaxdyn is the first Spanish biotech to be funded by CARB-X, a non-profit partnership investing $500 million in the development of innovative vaccines, ...
-
Lumen Bioscience Awarded $3.6 Million by U.S. Army to Advance Low-cost, Scalable Preventative for Antibiotic-Resistant Infections
Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced the receipt of a $3.6 million award from the Department of Defense (DoD) for advanced biomedical product development in support of Naval operations. The award from the Medical Technology Consortium (MTEC), a 501(c)(3) biomedical technology consortium ...
-
FDA Knew Devices Spread Fatal `Superbug`
U.S. health regulators have known since at least 2009 that the medical devices at the center of the "superbug" outbreak at UCLA can transmit lethal infections but have not recommended any new safety requirements, a lapse that threatens patient safety, experts in hospital-acquired infections said. The latest outbreak involving the reusable devices called duodenoscopes, which are inserted down the ...
-
Selux Diagnostics Earns FDA Breakthrough Device Designation for Next Generation `Phenotyping` (NGP) Platform for Positive Blood Culture and Sterile Body Fluid samples
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for positive blood culture and sterile body fluid samples. "While currently under review ...
-
Pet Store Puppies and Multidrug-Resistant Campylobacter Infections Discussed in New Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production discusses a recent outbreak of multidrug-resistant Campylobacter infections in people that were linked to contact with pet store puppies. “Earlier this year, the Centers for Disease Control and Prevention (CDC), the U.S. Department of ...
-
FDA’s New Antibiotics Policy Fails to Protect Health
The U.S. Food & Drug Administration today released a long pending policy that lays out a voluntary approach to reducing the use of antibiotics in animals that are not sick. The policy, known as Guidance 213, was widely criticized by NRDC and other public interest organizations when it was released in draft form in April 2012, because it fails to require any changes in the use of antibiotics. ...
-
MRSA Outbreak Strikes at High School
Thirteen students have tested positive for the antibiotic resistant infection, Methicillin-resistant Staphylococcus aureus (MRSA) at Belen High School in New Mexico. All thirteen of the students have received antibiotics and are expected to recover. A female cheerleader, the first one at Belen High to be diagnosed with MRSA, had the most severe case that required an abscess to be ...
-
Infection Control Resources for Candida auris and Other Superbugs
The Centers for Disease Control and Prevention (CDC) established the Antibiotic Resistance Laboratory Network (AR Lab Network) in all 50 states back in 2016. It was designed to help detect new forms of drug resistance from germs like bacteria and fungi that develop the ability to defeat the drugs that were designed to kill them. Drug resistance has become a growing concern, especially in ...
-
Selux Diagnostics Earns FDA Breakthrough Device Designation for Next Generation ‘Phenotyping’ (NGP) Platform for Positive Blood Culture and Sterile Body Fluid Samples
Selux Diagnostics, Inc., which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, today announced that its Next Generation 'Phenotyping' (NGP) platform has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for positive blood culture and sterile body fluid samples. "While currently under review ...
-
Selux Diagnostics Receives $9.6 Million in Additional Funding, Speeding Development of Breakthrough Rapid AST Platform
Selux Diagnostics, Inc., which is leading a new era in personalized medicine to treat superbug infections and combat antibiotic resistance, today announced that it has been awarded an additional $9.6 million from the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and ...
-
Members of Maryland Family who Died had Influenza and MRSA
Last month, Fox News reported that three members of the same Maryland family had died of flu complications. Two of the three people who died had also been infected with methicillin-resistant Staphylococcus aureus (MRSA). The news came from researchers from the Centers for Disease Control and Prevention (CDC). The three individuals included a mother and her two grown children. Additional ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you